Gut microbial β-glucuronidases influence endobiotic homeostasis and are modulated by diverse therapeutics
Cell Host & Microbe · 2024
DOI: 10.1016/j.chom.2024.04.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Host & Microbe, 2024. Verfasst von Joshua B Simpson und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of North Carolina, Chapel Hill, NC, USA. Hauptthemen laut MEDLINE: Homeostasis, Gastrointestinal Microbiome, Glucuronidase. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIEHS NIH HHS, NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Hormones and neurotransmitters are essential to homeostasis, and their disruptions are connected to diseases ranging from cancer to anxiety. The differential reactivation of endobiotic glucuronides by gut microbial β-glucuronidase (GUS) enzymes may influence interindividual differences in the onset and treatment of disease. Using multi-omic, in vitro, and in vivo approaches, we show that germ-free mice have reduced levels of active endobiotics and that distinct gut microbial Loop 1 and FMN GUS enzymes drive hormone and neurotransmitter reactivation. We demonstrate that a range of FDA-approved drugs prevent this reactivation by intercepting the catalytic cycle of the enzymes in a conserved fashion. Finally, we find that inhibiting GUS in conventional mice reduces free serotonin and increases its inactive glucuronide in the serum and intestines. Our results illuminate the indispensability of gut microbial enzymes in sustaining endobiotic homeostasis and indicate that therapeutic disruptions of this metabolism promote interindividual response variabilities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of North Carolina, Chapel Hill, NC, USA.
- Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC, USA.
- Department of Pharmacology, University of North Carolina, Chapel Hill, NC, USA.
- Division of Oral and Craniofacial Health Sciences, Adams School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Department of Bioorganic Synthesis, Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands.
Förderung
- NIEHS NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
- NIDDK NIH HHS
- National Opinion Research Center
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Simpson, J. B., Walker, M. E., Sekela, J. J., Ivey, S. M., Jariwala, P. B., Storch, C. M., Kowalewski, M. E., Graboski, A. L., Lietzan, A. D., Walton, W. G., Davis, K. A., Cloer, E. W., Borlandelli, V., Hsiao, Y. C., Roberts, L. R., Perlman, D. H., Liang, X., Overkleeft, H. S., Bhatt, A. P., …, & Redinbo, M. R. (2024). Gut microbial β-glucuronidases influence endobiotic homeostasis and are modulated by diverse therapeutics. Cell Host & Microbe. https://doi.org/10.1016/j.chom.2024.04.018
Vancouver
Simpson JB, Walker ME, Sekela JJ, Ivey SM, Jariwala PB, Storch CM, et al. Gut microbial β-glucuronidases influence endobiotic homeostasis and are modulated by diverse therapeutics. Cell Host & Microbe. 2024. doi:10.1016/j.chom.2024.04.018
BibTeX
@article{Simpson2024,
author = {Simpson, Joshua B and Walker, Morgan E and Sekela, Joshua J and Ivey, Samantha M and Jariwala, Parth B and Storch, Cameron M and Kowalewski, Mark E and Graboski, Amanda L and Lietzan, Adam D and Walton, William G and Davis, Kacey A and Cloer, Erica W and Borlandelli, Valentina and Hsiao, Yun-Chung and Roberts, Lee R and Perlman, David H and Liang, Xue and Overkleeft, Hermen S and Bhatt, Aadra P and Lu, Kun and Redinbo, Matthew R},
title = {Gut microbial β-glucuronidases influence endobiotic homeostasis and are modulated by diverse therapeutics},
journal = {Cell Host & Microbe},
year = {2024},
doi = {10.1016/j.chom.2024.04.018}
}
EUVIMED